The investment firm co-led a $125 million Series A round for Ambros Therapeutics, a Vivek Ramaswamy co-founded company with a ...

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech.  | Vivek Ramaswamy has found ...

RA Capital Management has raised another $461 million to invest in private biotechs. The closing of the fund comes 15 months after RA Capital set up an inaugural venture fund that has already seen 25% ...

– RA Capital and OMERS Life Sciences provide up to $250 million loan facility to commercial-stage biopharma company ARS Pharma to propel further growth – BOSTON, Sept. 30, 2025 /PRNewswire/ -- RA ...

In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky’s RA Capital. If you want to skip our introduction and take a look at the top five stocks in ...

RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P. and related parties, including Peter Kolchinsky and Rajeev M. Shah, sold 116,046 shares of Vor Biopharma Inc. NASDAQ:VOR common stock on ...

BOSTON, July 22, 2025 /PRNewswire/ -- RA Capital Management, LP ("RA Capital") today announced the final close of its inaugural Planetary Health Fund (PHF), raising $120 million to invest in ...

RA Capital is one of the few mainstream biotech VCs wading into the psychedelics space. The VC firm has invested in three psychedelics startups since 2021. It's looking for companies with short acting ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Life science-focused venture capital firms Atlas Venture, F-Prime Capital, RA Capital Management, and Osage University Partners (OUP) have partnered to create ...

A firm that invests in healthcare and life sciences has raised more than a quarter of $1 billion for a new venture fund. Boston-based RA Capital Management said Monday that it had closed its inaugural ...

RA Capital Management has several bets in emerging therapies that use a cell’s own systems to get rid of the proteins that cause disease. Those investments are in biotechs targeting problem proteins ...

Eliem Therapeutics is launching with two drugs that are already in human tests for chronic pain and depression. The biotech was formed from two startups RA Capital has been incubating. It is part of a ...